Lindsay Dearden

Statistics

Publications

Citations

252

H-Index

Active since

2011

Affiliations

Janssen (United States)(Current)

St Thomas' Hospital

Janssen (Belgium)

Janssen (United Kingdom)

Lindsay Dearden is an author at Janssen (United States) specializing in prostate cancer, oncology, and metastatic castration-resistant prostate cancer.

Publications per year

2011–2021

Publications

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

Neeraj Agarwal, Kelly McQuarrie, Anders Bjartell et al. · The Lancet Oncology · 2019 · 116 citations · Full text

Pharmacy, Oncology, Urology +16

Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment

Lina Eliasson, Hayley M. de Freitas, Lindsay Dearden et al. · Clinical Therapeutics · 2017 · 49 citations · Full text

Business, Oncology, Cancer Control +16

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

Simon Chowdhury, Stéphane Oudard, Hiroji Uemura et al. · Advances in Therapy · 2019 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Hospital treatment and management in relapse of schizophrenia in the UK: associated costs

Janet Munro, Sarah Osborne, Lindsay Dearden et al. · The Psychiatrist · 2011 · 19 citations · Full text

Medicine, Pharmacoeconomics, Psychiatry +17

Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study

Claire Burbridge, Jason A. Randall, Joe Lawson et al. · Supportive Care in Cancer · 2019 · 17 citations

Medicine, Oncology, Psychology +17

1–5 of 7